Are Randomized Controlled Trials Necessary to Establish the Value of Implementing Pharmacogenomics in the Clinic?
Clinical Pharmacology & Therapeutics2019Vol. 106(2), pp. 284–286
Citations Over TimeTop 10% of 2019 papers
Abstract
The authors declared no competing interests for this work.
Related Papers
- → Metformin Pharmacogenomics: Biomarkers to Mechanisms(2014)17 cited
- → Applying pharmacogenomics to enhance the use of biomarkers for drug effect and drug safety(2006)15 cited
- → Introduction to Pharmacogenomics: Promises, Opportunities, and Limitations(2002)11 cited
- Pharmacogenomics and Rational Use of Drugs(2001)
- Pharmacogenomics and Individualized Medication(2001)